CYPRUS INSTITUTE FOR NEUROLOGY AND GENETICS R&D

Promoter – Financial Intermediary

THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH

Location

• Cyprus

Description

The project includes construction of an extension and purchase of equipment as well as the intangible cost of research activities at the Cyprus Institute of Neurology and Genetics.

Objectives

The purpose of the project is to enhance the services, research and academic activities performed at the Cyprus Institute of Neurology and Genetics. The EIB will mainly support investments in new research and development (R&D) infrastructure as well as research programmes. The project is fully consistent with the Bank's Knowledge Economy objectives and the targets agreed in the context of the EU Horizon 2020.

Sector(s)

• Services
• Health

Proposed EIB finance (Approximate amount)

EUR 21 million

Total cost (Approximate amount)

EUR 31 million

Environmental aspects

Hospitals and medical research institutes are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2011/92/EU as amended, though the project is covered by Annex II of the directive in relation to urban development. The Bank's services will verify during appraisal whether an EIA is required by the competent authority.

Procurement

The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directives 2004/18/EC or 2014/24/EU where applicable, and/or 2004/17/EC, or 2014/25/EU where applicable, as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.

Status

Signed - 1/06/2017